Ki67 is one of the most widely studied molecular biomarkers in prostate cancers with several studies showing it to be of prognostic value, both independently and in conjunction with other prognostic indicators, especially the Gleason grades of these cancers [7-9]. This evidence concerns the gene MKI67 and cancer.